Comparison of Clinical and Pathological Factors Affecting Early and Late Recurrences in Patients with Operable Breast Cancer


YEKEDÜZ E. , DİZDAR Ö. , KERTMEN N. , AKSOY S.

JOURNAL OF CLINICAL MEDICINE, vol.11, no.9, 2022 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 9
  • Publication Date: 2022
  • Doi Number: 10.3390/jcm11092332
  • Title of Journal : JOURNAL OF CLINICAL MEDICINE
  • Keywords: breast cancer, early recurrence, late recurrence, disease-free survival, DISEASE-FREE SURVIVAL, TUMOR CHARACTERISTICS, INITIAL TREATMENT, HAZARD, DEPENDENCE, INVASION, RELAPSE, SIZE, TIME

Abstract

In this study, we aimed to assess clinicopathological factors affecting early and late recurrences in patients with operable breast cancer. Patients with early (<= 5 years) and late (>5 years) recurrences were assessed. Prognostic factors for disease-free survival (DFS) were also evaluated in patients with recurrence. A total of 854 patients were included. There were 432 and 205 patients in the early and late recurrence groups, respectively. In multivariate analyses, HER2+ disease, lymph node metastasis, lymphovascular invasion (LVI), and high tumor grade were associated with increased risk of early recurrence, while HER2+ disease and LVI were associated with decreased risk of late recurrence. In multivariate analyses, presence of HER2+ disease and triple-negative breast cancer (TNBC) were poor prognostic factors for DFS in patients with early recurrence. Presence of LVI and perineural invasion (PNI) were poor prognostic factors for DFS in patients with late recurrence. Molecular subtypes and LVI were effective on the early and late recurrences. However, lymph node positivity and grade were only associated with the early recurrence. After 5 years, LVI and PNI were the prognostic factors for DFS.